This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bar-Ilan University, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 246 
1 out of 915 
Years Active: 2026
Title: Amos Markus - Innovator in Ocular Angiogenesis
Introduction
Amos Markus is an inventor based in Petah Tikva, Israel. He has made significant contributions to the field of ocular angiogenesis through his research and patent applications. Although he currently holds no granted patents, his work is noteworthy for its potential impact on ophthalmological treatments.
Latest Patent Applications
Amos Markus has submitted a patent application titled "Conjugates Comprising Ocular Angiogenesis Growth Factor Aptamers and Uses Thereof in the Detection and Treatment of Ophthalmological Angiogenesis Indications." This application describes an antiangiogenic agent in the form of a vehicle, such as a nanoparticle, associated with at least one ocular angiogenesis growth factor aptamer. The association is designed to be labile to interaction between the aptamer and an ocular angiogenesis growth factor.
Conclusion
Amos Markus is an innovative thinker in the realm of ocular health, and his research may pave the way for future advancements in the treatment of eye-related conditions. His contributions, although not yet reflected in granted patents, demonstrate his commitment to improving medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile